Murray D. Bailey

2.9k total citations
25 papers, 1.2k citations indexed

About

Murray D. Bailey is a scholar working on Hepatology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Murray D. Bailey has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 9 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in Murray D. Bailey's work include Hepatitis C virus research (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and HIV/AIDS drug development and treatment (8 papers). Murray D. Bailey is often cited by papers focused on Hepatitis C virus research (13 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and HIV/AIDS drug development and treatment (8 papers). Murray D. Bailey collaborates with scholars based in Canada, Germany and Egypt. Murray D. Bailey's co-authors include Ted Halmos, Pat Forgione, François Bilodeau, Miguel St‐Onge, Marie‐Christine Brochu, Montse Llinàs‐Brunet, Martin Poirier, Vida Gorys, Élise Ghiro and Daniel Lamarre and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Murray D. Bailey

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murray D. Bailey Canada 15 609 465 321 273 230 25 1.2k
Martin Poirier Canada 21 438 0.7× 555 1.2× 420 1.3× 350 1.3× 249 1.1× 35 1.3k
Vida Gorys Canada 14 419 0.7× 347 0.7× 296 0.9× 230 0.8× 139 0.6× 21 827
Marc‐André Poupart Canada 18 391 0.6× 550 1.2× 520 1.6× 346 1.3× 303 1.3× 29 1.3k
James Gillard Canada 19 469 0.8× 330 0.7× 314 1.0× 273 1.0× 177 0.8× 30 975
Ted Halmos Canada 12 202 0.3× 451 1.0× 255 0.8× 252 0.9× 215 0.9× 15 747
Montse Llinàs‐Brunet Canada 25 497 0.8× 908 2.0× 502 1.6× 571 2.1× 421 1.8× 51 1.6k
Élise Ghiro Canada 11 258 0.4× 251 0.5× 210 0.7× 166 0.6× 120 0.5× 15 582
Stefania Colarusso Italy 12 218 0.4× 295 0.6× 184 0.6× 174 0.6× 144 0.6× 16 619
Keith F. McDaniel United States 17 413 0.7× 207 0.4× 281 0.9× 175 0.6× 196 0.9× 37 861
Srikanth Venkatraman United States 24 1.0k 1.7× 230 0.5× 410 1.3× 193 0.7× 118 0.5× 50 1.4k

Countries citing papers authored by Murray D. Bailey

Since Specialization
Citations

This map shows the geographic impact of Murray D. Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray D. Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray D. Bailey more than expected).

Fields of papers citing papers by Murray D. Bailey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray D. Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray D. Bailey. The network helps show where Murray D. Bailey may publish in the future.

Co-authorship network of co-authors of Murray D. Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Murray D. Bailey. A scholar is included among the top collaborators of Murray D. Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray D. Bailey. Murray D. Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fader, Lee D., Rebekah Carson, Sébastien Morin, et al.. (2014). Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV. ACS Medicinal Chemistry Letters. 5(6). 711–716. 14 indexed citations
2.
Bailey, Murray D., Josée Bordeleau, Michel Garneau, et al.. (2013). Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: Discovery of potent succinamide inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(15). 4447–4452.
3.
Bilodeau, François, Murray D. Bailey, Josée Bordeleau, et al.. (2013). Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs. Bioorganic & Medicinal Chemistry Letters. 23(14). 4267–4271. 4 indexed citations
4.
Bailey, Murray D., et al.. (2013). Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease. Bioorganic & Medicinal Chemistry Letters. 23(15). 4436–4440. 1 indexed citations
5.
Kawai, Stephen H., Murray D. Bailey, Ted Halmos, et al.. (2008). The Use of Chemical Double‐Mutant Cycles in Biomolecular Recognition Studies: Application to HCV NS3 Protease Inhibitors. ChemMedChem. 3(11). 1654–1657. 13 indexed citations
6.
Forgione, Pat, et al.. (2006). Unexpected Intermolecular Pd-Catalyzed Cross-Coupling Reaction Employing Heteroaromatic Carboxylic Acids as Coupling Partners. Journal of the American Chemical Society. 128(35). 11350–11351. 333 indexed citations
7.
Beaulieu, Pierre L., James Gillard, Murray D. Bailey, et al.. (2005). Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Vinyl-ACCA) Derivatives:  Key Intermediates for the Preparation of Inhibitors of the Hepatitis C Virus NS3 Protease. The Journal of Organic Chemistry. 70(15). 5869–5879. 65 indexed citations
8.
Bailey, Murray D., Ted Halmos, Nathalie Goudreau, Ewen Lescop, & Montse Llinàs‐Brunet. (2004). Novel Azapeptide Inhibitors of Hepatitis C Virus Serine Protease. Journal of Medicinal Chemistry. 47(15). 3788–3799. 28 indexed citations
9.
Faucher, Anne‐Marie, Murray D. Bailey, Pierre L. Beaulieu, et al.. (2004). Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans. Organic Letters. 6(17). 2901–2904. 74 indexed citations
10.
Pause, Arnim, George Kukolj, Murray D. Bailey, et al.. (2003). An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNA. Journal of Biological Chemistry. 278(22). 20374–20380. 74 indexed citations
11.
Khayat, Reza, et al.. (2003). Structural and Biochemical Studies of Inhibitor Binding to Human Cytomegalovirus Protease. Biochemistry. 42(4). 885–891. 16 indexed citations
12.
Llinàs‐Brunet, Montse, Murray D. Bailey, Gulrez Fazal, et al.. (2000). Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(20). 2267–2270. 78 indexed citations
13.
Simoneau, Bruno, Pierre Lavallée, Paul C. Anderson, et al.. (1999). Discovery of non-peptidic P2–P3 butanediamide renin inhibitors with high oral efficacy. Bioorganic & Medicinal Chemistry. 7(3). 489–508. 27 indexed citations
14.
Beaulieu, Pierre L., James Gillard, Murray D. Bailey, et al.. (1999). Practical Synthesis of BILA 2157 BS, a Potent and Orally Active Renin Inhibitor:  Use of an Enzyme-Catalyzed Hydrolysis for the Preparation of Homochiral Succinic Acid Derivatives. The Journal of Organic Chemistry. 64(18). 6622–6634. 25 indexed citations
15.
Anderson, Paul C., Murray D. Bailey, Pierre Lavallée, et al.. (1998). Novel small renin inhibitors containing 4,5- or 3,5-dihydroxy-2-substituted-6-phenylhexanamide replacements at the P2P3 sites. Bioorganic & Medicinal Chemistry. 6(12). 2317–2336. 2 indexed citations
16.
Bailey, Murray D.. (1998). Controversies in Vaccination with Measles, Mumps, Rubella (MMR) Vaccine. The Australian Journal of Hospital Pharmacy. 28(6). 443–444. 2 indexed citations
17.
Llinàs‐Brunet, Montse, Murray D. Bailey, Gulrez Fazal, et al.. (1998). Peptide-based inhibitors of the hepatitis C virus serine protease. Bioorganic & Medicinal Chemistry Letters. 8(13). 1713–1718. 113 indexed citations
18.
Llinàs‐Brunet, Montse, Murray D. Bailey, Robert Déziel, et al.. (1998). Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease. Bioorganic & Medicinal Chemistry Letters. 8(19). 2719–2724. 60 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Poirier Breakdown of academic impact, for papers by Vida Gorys Breakdown of academic impact, for papers by Marc‐André Poupart Breakdown of academic impact, for papers by James Gillard Breakdown of academic impact, for papers by Ted Halmos Breakdown of academic impact, for papers by Montse Llinàs‐Brunet Breakdown of academic impact, for papers by Élise Ghiro Breakdown of academic impact, for papers by Stefania Colarusso Breakdown of academic impact, for papers by Keith F. McDaniel Breakdown of academic impact, for papers by Srikanth Venkatraman
Rankless by CCL
2026